Why is Bliss GVS Pharma falling/rising?

As of 04-Aug, Bliss GVS Pharma Ltd is experiencing a price increase, currently at Rs 179.55, which reflects a rise of Rs 5.82 or 3.35%. The stock has shown a notable performance today, having outperformed its sector by 3.01% and marking a trend reversal after two consecutive days of decline. It reached an intraday high of Rs 183.1, indicating strong upward momentum. Over the past week, the stock has gained 15.76%, significantly outperforming the Sensex, which only increased by 0.16%. Despite a recent drop in investor participation, with delivery volume falling by 76.21% against the 5-day average, the stock remains liquid enough for trading. The company maintains a low debt-to-equity ratio and has generated a substantial return of 51.78% over the past year, although profits have decreased by 3.6%.
In the broader market context, Bliss GVS Pharma's short-term performance stands in stark contrast to the Sensex, which has declined by 2.89% over the past month. This indicates that while the overall market may be struggling, Bliss GVS Pharma has managed to achieve a positive trajectory. The stock's long-term performance is also commendable, having outperformed the BSE500 over various time frames, including the last three years. This consistent outperformance suggests that investors may still have confidence in the company's potential, despite the recent dip in profits. Overall, the stock's rise can be attributed to its strong performance metrics and favorable comparisons to the broader market.